Journal of Lipid Research, Vol 22, 1265-1270, Copyright © 1981 by Lipid Research, Inc.

ARTICLES

Inhibition of the lipolytic action of beta-adrenergic agonists in human adipocytes by alpha-adrenergic agonists

EE Wright and ER Simpson

The aim of this study was to define the role of the alpha-adrenergic receptor in the regulation of lipolysis by human adipocytes. Glycerol production by isolated human adipocytes was stimulated by the pure beta- adrenergic agonist isoproterenol in a dose-dependent fashion. This stimulation of lipolysis was inhibited by the alpha-adrenergic agonists methoxamine, phenylephrine, and clonidine. Epinephrine-stimulated lipolysis was potentiated by the alpha-adrenergic antagonists, dihydroergocryptine, phentolamine, phenoxybenzamine, and yohimbine. Whereas the attenuation of beta-adrenergic agonist-stimulated lipolysis by alpha-adrenergic agonists was reversed completely by the alpha 2- adrenergic antagonist yohimbine, the alpha 1-antagonist prazosin did not reverse such attenuation. It is concluded that alpha-adrenergic agonists act as antilipolytic agents in human adipocytes and that this action may result from the interaction of these compounds with a population of alpha 2-adrenergic receptors.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. F. Schäfers, J. Nürnberger, B. Herrmann, R. R. Wenzel, T. Philipp, and M. C. Michel Adrenoceptors Mediating the Cardiovascular and Metabolic Effects of alpha -Methylnoradrenaline in Humans J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 918 - 925. [Abstract] [Full Text]